Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-10-035630
Filing Date
2010-07-01
Accepted
2010-07-01 19:55:58
Documents
1
Period of Report
2010-06-29

Document Format Files

Seq Description Document Type Size
1 EXIT FORM 4 rrd280014.html 4  
1 EXIT FORM 4 rrd280014.xml 4 3466
  Complete submission text file 0001181431-10-035630.txt   5531
Mailing Address 950 TOWER LANE SUITE 900 FOSTER CITY CA 94404-2125
Business Address 950 TOWER LANE SUITE 900 FOSTER CITY CA 94404-2125 650-358-3456
SCICLONE PHARMACEUTICALS INC (Issuer) CIK: 0000880771 (see all company filings)

EIN.: 943116852 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 77-6F AVENIDA ARRIAGA EDIFICIO MARINA FORUM FUNCHAL-MADEIRA S1 P-9000
Business Address 77-6F AVENIDA ARRIAGA EDIFICIO MARINA FORUM FUNCHAL-MADEIRA S1 P-9000 351 291 20 24 00
Chaumiere Consultadoria & Servicos SDC Unipessoal LDA (Reporting) CIK: 0001330564 (see all company filings)

State of Incorp.: S1
Type: 4 | Act: 34 | File No.: 000-19825 | Film No.: 10932269